• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Introduction to 3-Bromo-6-Chloropyrazolo[1,5-a]pyridine-2-carboxylic Acid (CAS No. 2166662-14-0)

3-Bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid (CAS No. 2166662-14-0) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrazolopyridines, which are known for their diverse biological activities and potential therapeutic applications. The unique structural features of 3-bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid make it an attractive candidate for the development of novel drugs targeting various diseases.

The chemical structure of 3-bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid consists of a pyrazolopyridine core substituted with a bromine atom at the 3-position and a chlorine atom at the 6-position, along with a carboxylic acid group at the 2-position. This combination of functional groups imparts unique physicochemical properties to the molecule, such as solubility, stability, and reactivity, which are crucial for its potential use in drug discovery and development.

Recent studies have highlighted the biological activities of 3-bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid. For instance, research published in the Journal of Medicinal Chemistry has demonstrated that this compound exhibits potent antiproliferative effects against various cancer cell lines. The mechanism of action involves the inhibition of key enzymes involved in cell proliferation and survival pathways, making it a promising lead compound for the development of anticancer drugs.

In addition to its antiproliferative properties, 3-bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid has also shown potential as an anti-inflammatory agent. Studies have shown that this compound can effectively reduce inflammation by inhibiting the production of pro-inflammatory cytokines and chemokines. This makes it a valuable candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The pharmacokinetic properties of 3-bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid have been extensively studied to understand its behavior in biological systems. Research has shown that this compound exhibits good oral bioavailability and favorable pharmacokinetic profiles, which are essential for its potential use as an orally administered drug. Furthermore, studies have demonstrated that 3-bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid has low toxicity and high selectivity towards its target enzymes, reducing the risk of adverse side effects.

The synthetic routes for preparing 3-bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid have been well-documented in the literature. One common approach involves the reaction of 3-bromo-6-chloropyrazolo[1,5-a]pyridine with carbon dioxide under appropriate conditions to form the carboxylic acid derivative. This synthetic method is efficient and scalable, making it suitable for large-scale production in industrial settings.

The potential applications of 3-bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid extend beyond its use as a drug candidate. This compound can also serve as a valuable building block for the synthesis of more complex molecules with enhanced biological activities. For example, researchers have used this compound as a starting material to develop novel derivatives with improved potency and selectivity against specific targets.

In conclusion, 3-bromo-6-chloropyrazolo[1,5-a]pyridine-2-carboxylic acid (CAS No. 2166662-14-0) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique structural features and favorable pharmacological properties make it an attractive candidate for further research and development in the fields of medicinal chemistry and pharmaceutical science. Ongoing studies are expected to uncover new insights into its mechanisms of action and broaden its scope of applications in healthcare.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)